Displaying 1 - 20 of 36
Sanofi/Maze Therapeutics, Inc., In the Matter of
On December 13, 2023, the FTC moved to dismiss its case challenging the transaction following Sanofi’s decision to terminate its transaction with Maze Therapeutics Inc.
FTC Seeks to Block Sanofi’s Acquisition of Rare Disease Drug that Threatens Sanofi’s Monopoly
Board of Dental Examiners of Alabama; Analysis of Agreement Containing Consent Order To Aid Public Comment
Statement of Commissioner Rohit Chopra in the Matter of CoreLogic, Inc.
Joint Statement of Commissioners Christine S. Wilson and Noah Joshua Phillips in the Matter of CoreLogic, Inc.
Pfizer Inc. and Mylan N.V.; Analysis of Agreement Containing Consent Orders To Aid Public Comment
FTC Comments to State Legislatures in Kansas and Ohio Encourage Granting Advanced Practice Registered Nurses Full Practice Authority
FTC Staff Issues Comment on Proposed Occupational Licensing Reform in Nebraska
FTC Posts Blog on Voices for Liberty Video Project
Opening Doors to Opportunity: Frauds Impacting Arizona Consumers & Businesses and Streamlining Government Regulation
FTC Staff: Proposed Pennsylvania Legislation Affecting Nurse Practitioners Likely to Benefit Competition and Consumers while Promoting Principles of Economic Liberty
The Effects of Occupational Licensure on Competition, Consumers, and the Workforce: Empirical Research and Results
FTC to Hold Second Roundtable on Economic Liberty
FTC Announces Agenda for Second Economic Liberty Public Roundtable
FTC Testifies before House Judiciary Subcommittee About the Competitive Effects of Occupational Licensing Restrictions
Prepared Statement of the Â鶹´«Ã½ Trade Commission on Competition and Occupational Licensure, Before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Judiciary Committee, United States House of Representatives
Displaying 1 - 20 of 36